Skip to main content
Log in

[3H]cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: Allosteric modulation by paroxetine

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

We studied the characteristics of [3H]cocaine binding to membranes prepared from whole guinea pig brain. Cocaine binding was specific and saturable. A one-site binding model fit the data adequately: the Kd value of [3H]cocaine was 44 nM with a Bmax value of 280 fmol/mg protein. The rank order of potency for the [3H]cocaine binding site was paroxetine > clomipramine > (−)-cocaine > fluoxetine > mazindol > desipramine > GBR12909 > phencyclidine > benztropine > GBR12935 > (+)-cocaine. The IC50 values of these drugs for inhibition of [3H]cocaine binding were highly correlated with their IC50 values for inhibition of [3H]5-HT uptake into synaptosomes prepared from whole guinea pig brain. High affinity 5-HT uptake inhibitors produced dose-dependent wash-resistant (pseudoirreversible) inhibition of [3H]cocaine binding. The wash-resistant inhibition produced by paroxetine was due to an increase in the Kd of [3H]cocaine binding sites, and was accompanied by an increase in the dissociation rate, consistent with an allosteric mechanism. These studies suggest that, using membranes prepared from whole guinea pig brain, [3H]cocaine labels a binding site associated with serotonin transporter and that paroxetine and cocaine bind to different sites on the serotonin transporter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

GBR12909:

1-(2-{bis(4-fluorophenyl)methoxy}ethyl)-4-{3-phenylpropyl}piperazine

TCP:

1-{1-(2-thienyl)cyclohexyl}piperidine

BTCP:

N-{1-(2-benzo(b)thiophenyl)cyclohexyl}piperidine

PCP:

1-(1-phenylcyclohexyl)piperidine

GBR12935:

(1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine)

CMI:

clomipramine

References

  1. Van Dyke, C. 1981. Baltimore: Williams and Wilkins, Cocaine, in: Substance Abuse: Clinical Problems and Perspectives, pp. 158–166.

    Google Scholar 

  2. Post, R. M., and Contel, N. R. 1983. Human and animal studies of cocaine:implications for development of behavioral pathology. Pages 169–203,in Creese 1 (ed) Stimulants:neurochemical behavioral and clinical perspectives.

  3. Pitts, D. K., and Marwah, J. 1987. Cocaine interaction with central monoaminergic neurotransmission. Pharmacol. Biochem. Behav. 26:453–461.

    PubMed  Google Scholar 

  4. Gold, M. S., and Vereby, K. 1984. The Psychopharmacology of cocaine. Psychiatr. Ann. 14:714–723.

    Google Scholar 

  5. Ross, R. B., and Renyi, A. L. 1967. Inhibition of the uptake of tritiated catecholamines by anti-depressants and related compounds. Eur. J. Pharmacol. 2:181–186.

    PubMed  Google Scholar 

  6. Koe, B. K. 1976. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199:649.

    PubMed  Google Scholar 

  7. Sershen, H., Reith, M. E. A., and Lajtha, A. 1980. The pharmacological relevance of the cocaine binding site in mouse brain. Neuropharmacol. 19:1145–1148.

    Google Scholar 

  8. Sershen, H., Reith, M. E., and Lajtha, A. 1982. Comparison of the properties of central and peripheral binding sites for cocaine. Neuropharmacology. 21:469–474.

    PubMed  Google Scholar 

  9. Kennedy, L. T., and Hanbauer, I. 1983. Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J. Neurochem. 41:172–178.

    PubMed  Google Scholar 

  10. Calligaro, D. O., and Eldefrawi, M. E. 1988. High affinity stereospecific binding of [3H]cocaine in striatum and its relationship to the dopamine transporter. Memb Biochem 7:87–106.

    Google Scholar 

  11. Ritz, M. C., Lamb, R. J., Goldberg, S. R., and Kuhar, M. J. 1987. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219–1223.

    PubMed  Google Scholar 

  12. Imperato, A., Puglisi-Allegra, S., Zocchi, A., Scrocco, M. G., Casolini, P., and Angelucci, L. 1990. Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam. Eur. J. Pharmacol. 175:211–214.

    PubMed  Google Scholar 

  13. Imperato, A., and Angelucci, L. 1989. 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett. 101:214–217.

    PubMed  Google Scholar 

  14. Jiang, L. H., Ashby, C. R., Jr., Kasser, R. J., Wang, R. Y. 1990. The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res. 513:156–160.

    PubMed  Google Scholar 

  15. Ashby, C. R., Jr., Jiang, L. H., and Wang, R. Y. 1990. Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneiously active midbrain dopamine neurons. Eur. J. Pharmacol. 175:347–350.

    PubMed  Google Scholar 

  16. Reith, M. E., Sershen, H., Allen, D. L., and Lajtha, A. 1983. A portion of [3H]cocaine binding in brain is associated with serotonergic neurons. Mol. Pharmacol. 23:600–606.

    PubMed  Google Scholar 

  17. Rothman, R. B. 1986. Binding surface analysis: an intuitive yet quantitative method for the design and analysis of ligand binding studies. Alcohol and Drug Res. 6:309–325.

    Google Scholar 

  18. Rothman, R. B., Long, J. B., Bykov, V., Jacobson, A. E., Rice, K. C., and Holaday, J. W. 1988. Beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. J. Pharmacol. Exp. Ther. 247:405–416.

    PubMed  Google Scholar 

  19. Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.

    PubMed  Google Scholar 

  20. Rodbard, D., Lenox, R. H., Wray, L., and Ramseth, D. 1976. Statistical characterization of the random errors in the radioimmunoassay dose-response variable. Clin. Chem. 22:350–358.

    PubMed  Google Scholar 

  21. Rovati, G. E., Rodbard, D., and Munson, P. J. 1988. DESIGN: computerized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. I. Homologous and heterologous binding to one or two classes of sites. Anal. Biochem. 174:636–649.

    PubMed  Google Scholar 

  22. McGonigle, P., Neve, K. A., and Molinoff, P. B. 1986. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol. Pharmacol. 30:329–337.

    PubMed  Google Scholar 

  23. Knott, G. D., and Reece, D. K. 1972. MLAB: a civilized curve fitting system. Proceedings of the Online 1972 International Conference 1:497–526.

    Google Scholar 

  24. Rothman, R. B., Reid, A. A., Monn, J. A., Jacobson, A. E., and Rice, K. C. 1989. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites. Mol. Pharmacol. 36:887–896.

    PubMed  Google Scholar 

  25. Van der Zee, P., Koger, H. S., Gootjes, J., and Hespe, W. 1980. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15:363–370.

    Google Scholar 

  26. De Costa, B. R., George, C., and Dominguez, C. 1992. Approach to isothiocyanato-N-[1-(2-benzo(b)thiophenyl)cyclohexyl}piperidine, potential irreversible ligands at the dopamine transporter site. J. Chem. Soc. Perk. Trans. I. (In Press).

  27. Marcusson, J. O., Bergstrom, M., Eriksson, K., and Ross, S. B. 1988. Characterization of [3H]paroxetine binding in rat brain. J. Neurochem. 50:1783–1790.

    PubMed  Google Scholar 

  28. De Souza, E. B., and Kuyatt, B. L. 1987. Autoradiographic localization of3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse. 1:488–496.

    PubMed  Google Scholar 

  29. Reith, M. E., Sershen, H., and Lajtha, A. 1981. Binding of [3H]cocaine in mouse brain: kinetics and saturability. J. Recept. Res. 2:233–243.

    PubMed  Google Scholar 

  30. Reith, M. E. A., Sershen, H., and Lajtha, A. 1986. Binding site for [3H]cocaine in mouse striatum and cerebral cortex have different dissociation kinetics. J. Neurochem. 46:309–312.

    PubMed  Google Scholar 

  31. Andersen, P. H. 1989. The dopamine uptake inhibitor GBR12909, selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166:493–504.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akunne, H.C., de Costa, B.R., Jacobson, A.E. et al. [3H]cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: Allosteric modulation by paroxetine. Neurochem Res 17, 1275–1283 (1992). https://doi.org/10.1007/BF00968412

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00968412

Key Words

Navigation